Medicare Enrolled

Dr. Nathan Yerger, M.D.

Family Medicine · Midlothian, TX
Low-engagement
979 DON FLOYD DR STE 124, Midlothian, TX 76065
9727754132
In practice since 2008 (17 years)
NPI: 1609011444 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yerger from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yerger? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yerger

Dr. Nathan Yerger is a family medicine in Midlothian, TX, with 17 years in practice.

Between the years covered by Open Payments, Dr. Yerger received a total of $5,885 from 36 pharmaceutical and/or device companies across 387 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yerger is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice$ $5,885 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$5,885
Total received (2018-2024)
Avg $841/year across 7 years
Top 11% in TX for family medicine
36
Companies
387
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,885 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$562
2023
$763
2022
$1,144
2021
$1,171
2020
$1,024
2019
$850
2018
$372

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$874
Novo Nordisk Inc
$721
Amgen Inc.
$470
AbbVie Inc.
$395
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$348
Abbott Laboratories
$322
Mylan Specialty L.P.
$313
GlaxoSmithKline, LLC.
$262
SANOFI-AVENTIS U.S. LLC
$238
Bayer HealthCare Pharmaceuticals Inc.
$210
ABBVIE INC.
$205
Allergan, Inc.
$138
Allergan Inc.
$127
Lilly USA, LLC
$125
PFIZER INC.
$110
Takeda Pharmaceuticals U.S.A., Inc.
$100
Boehringer Ingelheim Pharmaceuticals, Inc.
$99
ITI, Inc.
$97
Otsuka America Pharmaceutical, Inc.
$87
Merck Sharp & Dohme Corporation
$85
Astellas Pharma US Inc
$82
AngioDynamics, Inc.
$73
Merck Sharp & Dohme LLC
$69
Radius Health, Inc.
$56
Amarin Pharma Inc.
$48
Esperion Therapeutics, Inc.
$36
Biohaven Pharmaceutical Holding Company Ltd.
$33
Smith+Nephew, Inc.
$28
Biogen, Inc.
$28
Phathom Pharmaceuticals, Inc.
$19
Eisai Inc.
$17
Biohaven Pharmaceuticals, Inc.
$16
Janssen Pharmaceuticals, Inc
$15
Bayer Healthcare Pharmaceuticals Inc.
$15
Supernus Pharmaceuticals, Inc.
$13
Dexcom, Inc.
$13
Top 3 companies account for 35.1% of total payments
Associated products mentioned in payments ›
ADUHELM · AIRSUPRA · AREXVY · Aimovig · Amitiza · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · CAPLYTA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · Dayvigo · Dexcom G6 Transmitter · Dymista · EMGALITY · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL 9 · JANUVIA · JARDIANCE · Kerendia · LINZESS · LYRICA · M-M-R II · MOUNJARO · MYRBETRIQ · NEXLETOL · NURTEC ODT · OFEV · Otezla · Ozempic · PREVNAR - 13 · Prolia · QELBREE · QULIPTA · REGRANEX · REXULTI · ROTATEQ · RYBELSUS · Rybelsus · SOLIQUA 100/33 · SYMBICORT · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · Tresiba · Trintellix · Tymlos · UBRELVY · VOQUEZNA · VRAYLAR · Vascepa · VenaCure 1470 Pro · Victoza · Wegovy · XARELTO · XIFAXAN · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a family medicine in Midlothian?
Compare family medicines in the Midlothian area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
515
Per 100K population
252.5
County median income
$95,898
Nearest hospital
METHODIST MIDLOTHIAN MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Yerger is a family medicine, and high industry engagement (low-engagement, top 11%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Yerger receive payments from pharmaceutical companies?
Yes. Dr. Yerger received a total of $5,885 from 36 companies across 387 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Yerger) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →